(NASDAQ: CRBU) Caribou Biosciences's forecast annual revenue growth rate of 84.07% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.38%.
Caribou Biosciences's revenue in 2025 is $7,565,000.On average, 4 Wall Street analysts forecast CRBU's revenue for 2025 to be $758,917,552, with the lowest CRBU revenue forecast at $223,211,045, and the highest CRBU revenue forecast at $952,367,124. On average, 3 Wall Street analysts forecast CRBU's revenue for 2026 to be $3,735,622,844, with the lowest CRBU revenue forecast at $930,046,020, and the highest CRBU revenue forecast at $9,300,460,200.
In 2027, CRBU is forecast to generate $3,898,752,916 in revenue, with the lowest revenue forecast at $1,000,729,518 and the highest revenue forecast at $9,300,460,200.